CD59 and colorectal cancer: The silencing of CD59 in HT-29 cells promoted cell sensitivity to the chemotherapeutic drugs 5-fluorouracil and oxaliplation by promoting apoptosis and blocking G0/G1 phases, which provided a guidance for combination chemotherapy of colorectal cancer [27].